Advancing Antithrombotic Stewardship to Optimise Care – American Heart Association
American Heart Association shared a post on LinkedIn about a recent article by Kelly Rudd et al, adding:
“Antithrombotic therapy is a cornerstone in the approach to reducing the complications of several vascular disorders, including atrial fibrillation (AF), venous thromboembolic disease (VTE), and peripheral vascular disease (PVD). However, balancing the benefits of thrombosis prevention and risks, particularly of medication-related bleeding, is a significant concern for healthcare providers.
Addressing antithrombotic undertreatment requires sustained system-level change, expansion of antithrombotic stewardship, improved access to therapy, and focused efforts within at-risk populations. As healthcare teams continue to strengthen interdisciplinary collaboration and integrate evidence-based, stewardship strategies, meaningful progress can be achieved in reducing preventable thrombotic events and improving long-term patient outcomes across AF, VTE, and PAD.
Summary of the impa.”
Title: Impact of Undertreated Antithrombotic Therapy on Adverse Patient Outcomes: A Scientific Statement From the American Heart Association
Authors: Kelly Rudd, Youssef Bessada, Geoffrey Barnes, Ulf Bronas, Ashley Budd, Taylor Goot, Natalie Montanez, Toby Trujillo

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health